Your session is about to expire
← Back to Search
Early Intervention for Pain Management in Cancer
N/A
Waitlist Available
Led By Andrea Enzinger, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks up to 4 months
Awards & highlights
Study Summary
This trial will test whether referring patients with cancer pain to a pain management specialist is feasible and helpful.
Who is the study for?
This trial is for adults over 21 with advanced or metastatic cancer, experiencing persistent pain rated at least a 4 out of 10. They should expect to live more than six months and have pain from cancer or its treatment. It's not for those with neuropathy, high opioid use, prior specialized pain care, bleeding risks, infections that can't be controlled, history of opioid misuse, or cognitive impairments.Check my eligibility
What is being tested?
The study tests the effectiveness of early referral to a pain specialist for managing cancer-related pain using various strategies and procedures designed to alleviate discomfort. The goal is to see if this approach helps patients better manage their cancer-associated pain.See study design
What are the potential side effects?
While specific side effects are not detailed here as it depends on the individualized interventions by the pain specialist, potential side effects may include discomfort from procedures used to manage pain and reactions related to any medications prescribed.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 weeks up to 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks up to 4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain Care Participation Rate
Pain Consultation Participation Rate
Satisfaction Ratings
Trial Design
1Treatment groups
Experimental Treatment
Group I: Pain management strategiesExperimental Treatment2 Interventions
Participants will receive early referral to an anesthesia-trained interventional pain management specialist evaluated for pain management strategies.
Participants will complete surveys every 2 months and will have the option of tracking their pain at home using a secure smartphone application.
Participants will be followed on the study for 4 months.
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,080 Previous Clinical Trials
340,904 Total Patients Enrolled
1 Trials studying Cancer Pain
54 Patients Enrolled for Cancer Pain
MedtronicIndustry Sponsor
608 Previous Clinical Trials
828,655 Total Patients Enrolled
Andrea Enzinger, MDPrincipal InvestigatorDana-Farber Cancer Institute
4 Previous Clinical Trials
319 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have trouble with memory or thinking that would make it hard for you to take part in the study or answer questions.You have been diagnosed with a cancer that has spread to other parts of the body or is not able to be surgically removed.Your doctor expects you to live for at least 6 more months.You are older than 21 years.You have been in pain for at least 2 weeks.You are experiencing pain because of cancer or past cancer treatments.You have ongoing pain that you rate as a 4 or higher on a scale from 0 to 10.Your main pain issue is from nerve damage in your arms or legs.You are currently taking more than 90 milligrams of morphine or a similar pain medication each day.You are currently being treated by a doctor who specializes in managing pain through medical procedures.You have received a pain treatment in the past, such as celiac neurolysis.You have a condition that causes uncontrolled bleeding, infection, or makes it unsafe to receive pain treatments.You have a history of misusing opioids.
Research Study Groups:
This trial has the following groups:- Group 1: Pain management strategies
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities currently available to participate in this clinical trial?
"Clinicaltrials.gov indicates that this medical trial is not presently recruiting patients, as the listing was first posted on October 1st 2022 and last edited May 4th 2022. However, there are 36 other trials actively seeking candidates right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger